MYC oncogene is frequently overexpressed in prostate tumors as a consequence of either somatic amplifications (8q24, advanced prostate cancers) or as consequence of deregulated expression (prostate intraepithelial neoplasia). The gene discussed is MYC; the disease is prostate carcinoma.